# Kiora Pharmaceuticals Inc: Form 8-K, filed Jun 6, 2023

- Company: [Kiora Pharmaceuticals Inc](/companies/kprx.md) (CIK 1372514)
- Form: 8-K
- Filed: 2023-06-06
- Accepted by EDGAR: Jun 6, 2023, 16:52 ET
- Period: 2023-06-02
- Accession: 0001372514-23-000097
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1372514/000137251423000097/kprx-20230602.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1372514/000137251423000097/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1372514/000137251423000097/kprx-20230602.htm

Filed Jun 6, 2023.
Source: SEC EDGAR, the filing index for accession 0001372514-23-000097. Last ingested by Listed: Nov 12, 2026, 17:43 ET. No prices; not investment advice.
